Literature DB >> 29723419

Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis.

Rebecca A Snyder1, Laura R Prakash2, Graciela M Nogueras-Gonzalez3, Michael P Kim2, Thomas A Aloia2, Jean-Nicolas Vauthey2, Jeffrey E Lee2, Jason B Fleming4, Matthew H G Katz2, Ching-Wei D Tzeng2.   

Abstract

BACKGROUND AND OBJECTIVES: Venous patency rates after pancreaticoduodenectomy (PD) with portal vein (PV) resection are not well established, and the oncologic impact of portal vein thrombosis (PVT) is unknown. The primary aim of this study was to determine rates and predictors of PVT after PD with PV resection for pancreatic adenocarcinoma (PDAC).
METHODS: A retrospective cohort study was performed on PDAC patients treated with preoperative therapy and PD with PV resection at a high-volume institution (2008-15). Primary outcomes were early and late PVT (≤ or >90 days of surgery). Secondary outcomes included major complications and OS.
RESULTS: Patients undergoing vein resection (N = 120) included 41.7% (N = 50) primary repair or patch venoplasty, 29.2% (N = 35) primary anastomosis, and 29.2% (N = 35) interposition graft. Thirty-four (28.3%) patients developed PVT (early 7.5% [N = 9]; late 20.8% [N = 25]). Late PVT was often detected concurrently with local recurrence (76.0%; N = 19). There was no association of PVT with vascular resection extent or complications (P > 0.05). On multivariable analysis, PVT was associated with worse OS (HR 2.2 [95% CI 1.34-3.5], P < 0.001).
CONCLUSIONS: Overall postoperative patency rates following PV resection PDAC were high. PVT is associated with worse OS, which appears less likely related to technical issues, but rather representative of disease biology.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  pancreatectomy; pancreatic neoplasms; venous thrombosis

Mesh:

Year:  2018        PMID: 29723419     DOI: 10.1002/jso.25067

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy.

Authors:  Bor-Uei Shyr; Shih-Chin Chen; Yi-Ming Shyr; Shin-E Wang
Journal:  Surg Endosc       Date:  2019-04-08       Impact factor: 4.584

2.  Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.

Authors:  Laura R Prakash; Huamin Wang; Jun Zhao; Graciela M Nogueras-Gonzalez; Jordan M Cloyd; Ching-Wei D Tzeng; Michael P Kim; Jeffrey E Lee; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

3.  Robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma: surgical and oncological outcomes from pilot experience.

Authors:  Jiabin Jin; Shih-Min Yin; Yuanchi Weng; Mengmin Chen; Yusheng Shi; Xiayang Ying; Georgios Gemenetzis; Kai Qin; Jun Zhang; Xiaxing Deng; Chenghong Peng; Baiyong Shen
Journal:  Langenbecks Arch Surg       Date:  2022-01-28       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.